Cytokine status’ pattern in acute period of ischemic stroke subtypes

Authors

  • S. I. Shkrobot State Institution of Higher Education “І. Horbachevskyy Ternopil State Medical University”, Ukraine,
  • N. R. Sokhor State Institution of Higher Education “І. Horbachevskyy Ternopil State Medical University”, Ukraine,
  • L. S. Milevska-Vovchuk State Institution of Higher Education “І. Horbachevskyy Ternopil State Medical University”, Ukraine,
  • L. V. Shkrobot State Institution of Higher Education “І. Horbachevskyy Ternopil State Medical University”, Ukraine,

DOI:

https://doi.org/10.14739/2310-1210.2017.3.100766

Keywords:

stroke, inflammation mediators

Abstract

Purpose The aim of this study was to assess a different pattern of inflammatory mediators in relation of ischemic stroke subtypes in acute period.

Materials and Methods. The study involved 482 patients with different ischemic stroke (IS) subtypes. We studied the content of inflammatory interleukins (IL-1β, IL-2, IL-6, IL-8, CRP, TNF-α) and anti-inflammatory interleukin IL-10 in blood serum.

Results The study revealed increasing content of pro-inflammatory cytokines in acute period of IS subtypes, especially at Large Artery AtheroSclerosis (LAAS) and CardioEmbolic Infarct (CEI). In patients with LAAS the level of IL-2, IL-6 and CRP was significantly higher compared to other IS subtypes. The content of IL-10 was significantly lower compared to patients with Undetermined Etiology (UDE) stroke and LACunar (LAC) stroke. We established the relationship between the concentration of IL-1β and IL-6 with the severity of LAAS, CEI and UDE on the 1st day of stroke. On the 7th day the concentration of IL-1β and IL-8 was significantly decreased at LAC, IL-2 – at LAC and LAAS, IL-6 and TNF-α at LAC and UDE. At LAAS the content of inflammatory mediators depended on the degree of arteries stenosis, the presence of unstable atherosclerotic plaques, the intima-media thickness. We found a direct relationship between the severity of LAAS and CEI on the 14th day with the CRP concentration on the 1st day (at LAAS – (r = 0.73, p = 0.003), at CEI – (r = 0.71, p = 0.002), indicating predictive value of CRP-content on the course of acute period of IS subtypes. We established the dependence between cardiac morphometric parameters with the level of pro-inflammatory interleukins in acute period of UDE. We found the relation between the content of IL-1β, IL-6 with left ventricular myocardial mass index at UDE.

Conclusions The content of inflammatory mediators in acute period of ischemic stroke depends on the pathogenic subtype of stroke.

References

Kim, J., Kawabori, M., & Yenari, M. (2014) Innate inflammatory responses in stroke: mechanisms and potential therapeutic targets. Current Medicinal Chemistry, 21(18), 2076–97.

Kawabori, M., & Yenari, M. (2015) Inflammatory responses in brain ischemia. Current Medicinal Chemistry, 22(10), 1258–77. doi: 10.2174/0929867322666150209154036.

Anrather, J., & Iadecola, C. (2016) Inflammation and Stroke: An Overview. Neurotherapeutics, 13(4), 661–670. doi: 10.1007/s13311-016-0483-x.

Tuttolomond, A., Di Raimond, D., Pecoraro, R., Arnao, V., Pinto, A., & Licatа, G. (2012) Inflammation in Ischemic Stroke Subtypes. Current Pharmaceutical Design, 18, 4289–4310.

Licata, G., Tuttolomondo, A., Di Raimondo, D., Corrao, S., Di Sciacca, R., & Pinto, A. (2009) Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischaemic stroke. Thrombosis and Haemostasis, 101(5), 929–937. doi: 10.1160/th08-06-0375.

Boehme, A. K., McClure, L. A., Zhang, Y., Luna, J. M., Del Brutto, O. H., Benavente, O. R., & Elkind, M. S. (2016) Inflammatory Markers and Outcomes After Lacunar Stroke: Levels of Inflammatory Markers in Treatment of Stroke Study. Stroke, 47(3), 659–67. doi: 10.1161/STROKEAHA.115.012166.

Welsh, P., Barber, M., Langhorne, P., Rumley, A., Lowe, J., & Stott, D. (2009) Associations of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke. Cerebrovascular Diseases, 27(3), 247–53. doi: 10.1159/000196823.

Shrivastava, A., Singh, H., Raizada, A., & Singh, S. (2015) C-reactive protein, inflammation and coronary heart disease. The Egyptian Heart Journal., 2015, 67(2), 89–97. doi: 10.1016/j.ehj.2014.11.005.

Elkind, M., Luna, J., & McClure, L. (2014) C-reactive protein as a prognostic marker after lacunar stroke: levels of inflammatory markers in the treatment of stroke study. Stroke, 45(3), 707–16. doi: 10.1161/STROKEAHA.113.004562.

Qiu, R., Gao, Y., Hou, D., Yu, C., Wang, W., Liu, S., et al. (2016) Association between hs-CRP Levels and the Outcomes of Patients with Small-Artery Occlusion. Frontiers in Aging Neuroscience, 9(8), 191. doi: 10.3389/fnagi.2016.00191.

Downloads

How to Cite

1.
Shkrobot SI, Sokhor NR, Milevska-Vovchuk LS, Shkrobot LV. Cytokine status’ pattern in acute period of ischemic stroke subtypes. Zaporozhye Medical Journal [Internet]. 2017May5 [cited 2024Nov.2];(3). Available from: http://zmj.zsmu.edu.ua/article/view/100766

Issue

No. 3 (2017)

Section

Original research

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.  Лицензия Creative Commons
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)